Stockscreener 앱 받기
287.70
0.42%
1.21
Insulet Corporation 주식(PODD)의 최신 뉴스
Chart Watch: What drives SWAGWs stock priceWeekly Stock Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Goldman Sachs Adjusts Price Target on Insulet to $363 From $365, Maintains Buy Rating - marketscreener.com
Nisa Investment Advisors LLC Sells 4,201 Shares of Insulet Corporation $PODD - MarketBeat
Wells Fargo Sticks to Their Buy Rating for Insulet (PODD) - The Globe and Mail
Bernstein Reduces Firm's PT on Insulet (PODD) Stock - Finviz
Bernstein Reduces Firm’s PT on Insulet (PODD) Stock - Insider Monkey
Bernstein reduces firm’s PT on Insulet (PODD) stock - MSN
Nordea Investment Management AB Has $125.13 Million Position in Insulet Corporation $PODD - MarketBeat
Insulet Corp (NASDAQ:PODD) Passes Key Growth Screen with Strong Momentum - Chartmill
Insulet Stock Is Going Off: Game-Changer For Diabetes Tech Or Just Hype? - AD HOC NEWS
Investment Recap: Will Insulet Corporation stock benefit from AI adoptionPortfolio Growth Summary & Free Real-Time Volume Trigger Notifications - moha.gov.vn
Trading Systems Reacting to (PODD) Volatility - Stock Traders Daily
Insulet Corporation (PODD) Stock Analysis: A 29.95% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Insulet Shares Fall After Barclays Downgrade - marketscreener.com
Barclays downgrades Insulet stock rating to Underweight on competition concerns - Investing.com
Insulet (PODD) Downgraded by Barclays with Lowered Price Target - GuruFocus
Barclays Downgrades Insulet to Underweight From Equal Weight, Adjusts Price Target to $274 From $316 - marketscreener.com
Barclays downgrades DexCom, Insulet as diabetes competition seen intensifying in 2 - Investing.com
Insulet (PODD) Downgraded by Barclays Amid Growing Competition - GuruFocus
Barclays Downgrades Insulet Corporation (PODD) to Underweight - StreetInsider
Insulet (NASDAQ:PODD) Downgraded to Equal Weight Rating by Barclays - MarketBeat
Aug Movers: Can Insulet Corporation ride the EV waveJuly 2025 Sentiment & High Return Trade Guides - baoquankhu1.vn
Insulin Patch Pump Market Is Going to Boom | Medtronic • Insulet Corporation • Tandem Diabetes Care - openPR.com
Why Analysts See The Insulet (PODD) Story Shifting As Omnipod Growth Meets Valuation Questions - Yahoo Finance
150,699 Shares in Insulet Corporation $PODD Bought by Parnassus Investments LLC - MarketBeat
Bernstein Lowers Price Target for Insulet (PODD) to $380, Mainta - GuruFocus
Assessing Insulet (PODD) Valuation After CES 2026 Spotlight On Omnipod 5 And Growth Prospects - Sahm
Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD) - FinancialContent
Here's Why Insulet (PODD) is a Strong Growth Stock - Yahoo Finance
Bernstein Adjusts Price Target on Insulet to $380 From $410, Maintains Outperform Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Insulet to $365 From $388, Maintains Buy Rating - marketscreener.com
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 - BioSpace
11,391 Shares in Insulet Corporation $PODD Purchased by Steinberganna Wealth Management - MarketBeat
Is Insulet Corporation stock a bargain at current levelsJuly 2025 Market Mood & Daily Growth Stock Tips - Улправда
Will Insulet Corporation stock outperform value stocksEarnings Trend Report & Reliable Breakout Stock Forecasts - ulpravda.ru
Trading Recap: Why hedge funds are buying Insulet Corporation stockMarket Rally & Free AI Powered Buy and Sell Recommendations - ulpravda.ru
Institution Moves: What margin trends mean for Insulet Corporation stockGap Up & Safe Entry Trade Reports - ulpravda.ru
What Provides InsuletCorp. (PODD) With a Durable Competitive Advantage? - Finviz
Pullback Watch: What margin trends mean for Insulet Corporation stockWeekly Trend Recap & Stock Market Timing Techniques - ulpravda.ru
Can Insulet Corporation stock hit record highs againTrade Entry Report & Technical Confirmation Alerts - ulpravda.ru
Can Insulet Corporation (GOV) stock resist broad market declinesWeekly Trading Summary & High Accuracy Investment Signals - ulpravda.ru
Asset Management One Co. Ltd. Has $11.86 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Insulet’s Human‑First Omnipod 5 CES Debut Might Change The Case For Investing In Insulet (PODD) - simplywall.st
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health - Business Wire
Declining Stock and Solid Fundamentals: Is The Market Wrong About Insulet Corporation (NASDAQ:PODD)? - Yahoo Finance
How Insulet Corporation (PODD) Affects Rotational Strategy Timing - Stock Traders Daily
Is it the Right Time to Add Insulet Stock to Your Portfolio? - Yahoo Finance
Will BluEnergies Ltd 66E stock benefit from infrastructure billJuly 2025 Update & Growth Focused Entry Reports - moha.gov.vn
Braun Stacey Associates Inc. Makes New Investment in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Insulet (PODD) - Zacks Investment Research
Insulet Corporation $PODD Shares Sold by Ayrshire Capital Management LLC - MarketBeat
From Edwards to Insulet: Three key medical device cases of 2025 - Life Sciences Intellectual Property Review
Insulet Corporation (NASDAQ:PODD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Swedbank AB Buys 5,000 Shares of Insulet Corporation $PODD - MarketBeat
Osaic Holdings Inc. Purchases 5,309 Shares of Insulet Corporation $PODD - MarketBeat
Beacon Investment Advisory Services Inc. Has $25.11 Million Stake in Insulet Corporation $PODD - MarketBeat
3 Reasons Growth Investors Will Love Insulet (PODD) - sharewise.com
0.15%
1.96%
자본화:
|
볼륨(24시간):